A reagent kit for the determination of immunoglobulins of class G (IgG) to the SARS-CoV-2 coronavirus that causes COVID-19 in human serum (plasma) by the method of enzyme-linked immunosorbent assay ELISA SARS-CoV-2 IgG Screen ", is intended for the qualitative determination of antibodies of class G (IgG) or for the qualitative simultaneous determination of antibodies of class G (IgG) to the SARS-CoV-2 coronavirus causing the" COVID-19 "disease in human blood serum (plasma) by applying the method of solid-phase indirect enzyme-linked immunosorbent assay (ELISA).
The use of the reagent kit "SARS-CoV-2 IgG Screen":
• diagnosis of COVID-19 in patients with acute respiratory syndrome;
• identification of asymptomatic and obliterated forms of COVID-19 in the foci of the disease;
• examination of SARS-CoV-2 virus contacts;
• examination of people arriving from regions with a high level of COVID-19 disease and their re-examination before leaving the observation;
• identification of patients with COVID-19 regardless of the form of the infection process;
• identification of potential donors of high-volume plasma, which can be used in the treatment of severe forms of COVID-19;
• studies to determine the duration and intensity of immunity to the SARS-CoV-2 virus.
